Micro-Tech (Nanjing) Co.,Ltd (SHA:688029)
China
· Delayed Price · Currency is CNY 84.09
+0.21 (0.25%)
Apr 29, 2026, 2:05 PM CST
SHA:688029 Revenue
Micro-Tech (Nanjing) Co.,Ltd had revenue of 853.73M CNY in the quarter ending March 31, 2026, with 22.11% growth. This brings the company's revenue in the last twelve months to 3.34B, up 17.78% year-over-year. In the year 2025, Micro-Tech (Nanjing) Co.,Ltd had annual revenue of 3.18B with 15.55% growth.
Revenue (ttm)
3.34B
Revenue Growth
+17.78%
P/S Ratio
4.70
Revenue / Employee
1.35M
Employees
2,407
Market Cap
15.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.18B | 428.35M | 15.55% |
| Dec 31, 2024 | 2.76B | 343.97M | 14.26% |
| Dec 31, 2023 | 2.41B | 431.32M | 21.78% |
| Dec 31, 2022 | 1.98B | 33.42M | 1.72% |
| Dec 31, 2021 | 1.95B | 620.32M | 46.77% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Qingdao NovelBeam Technology | 630.18M |
| Autek China | 1.84B |
| Jiangsu Hualan New Pharmaceutical Material | 604.86M |
| Shenyang Xingqi Pharmaceutical | 2.47B |
| Winner Medical | 11.02B |
| Tofflon Science and Technology Group | 5.22B |
| Eyebright Medical Technology (Beijing) | 1.52B |
| Sansure Biotech | 1.65B |